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Huntington’s disease (HD) is a neurodegenerative condition characterized by severe
neuronal loss in the cortex and striatum that leads to motor and behavioral deficits.
Excitotoxicity is thought to be involved in HD and several studies have indicated that
NMDA receptor (NMDAR) overactivation can play a role in the selective neuronal loss
found in HD. Interestingly, a small subset of striatal neurons (less than 1% of the
overall population) is found to be spared in post-mortem HD brains. These neurons
are medium-sized aspiny interneurons that highly express the neuronal isoform of
nitric oxide synthase (nNOS). Intriguingly, neurons expressing large amounts of nNOS
[hereafter indicated as nNOS(+) neurons] show reduced vulnerability to NMDAR-mediated
excitotoxicity. Mechanisms underlying this reduced vulnerability are still largely unknown
and may shed some light on pathogenic mechanisms involved in HD. One untested
possibility is that nNOS(+) neurons possess fewer or less functioning NMDARs.
Employing single cell calcium imaging we challenged this hypothesis and found that
cultured striatal nNOS(+) neurons show NMDAR-evoked responses that are identical to
the ones observed in the overall population of neurons that express lower levels of nNOS
[nNOS(−) neurons]. NMDAR-dependent deregulation of intraneuronal Ca2+ is known to
generate high levels of reactive oxygen species of mitochondrial origin (mt-ROS), a crucial
step in the excitotoxic cascade. With confocal imaging and dihydrorhodamine (DHR; a
ROS-sensitive probe) we compared mt-ROS levels generated by NMDAR activation in
nNOS(+) and (−) cultured striatal neurons. DHR experiments revealed that nNOS(+)
neurons failed to produce significant amounts of mt-ROS in response to NMDA exposure,
thereby providing a potential mechanism for their reduced vulnerability to excitotoxicity
and decreased vulnerability in HD.
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INTRODUCTION
Excitotoxicity is a major pathogenic component of sev-
eral neurodegenerative disorders, including Alzheimer’s dis-
ease, Parkinson’s disease, amyotrophic lateral sclerosis, and
Huntington’s disease (HD) (Choi, 2005; Lau and Tymianski,
2010; Spalloni et al., 2013). HD is an autosomal dominant
neurodegenerative condition characterized by severe behav-
ioral, cognitive, and movement disorders (Ross and Tabrizi,
2011). Inheritance of the huntingtin (Htt) protein showing a
pathogenic expansion of a glutamine stretch (polyQ repeats>35)
(Macdonald et al., 1993) leads to massive cortical and striatal
neuronal loss (Halliday et al., 1998; Cattaneo et al., 2005; Guo
et al., 2012). Reasons for this sub-regional selectivity of the neu-
rodegenerative process are not completely understood, although
several mechanisms have been proposed. In that respect, evidence
indicates that polyQ Htt promotes HD pathology through dereg-
ulation of vesicle trafficking (Difiglia et al., 1995; Qin et al., 2004),
alteration of BDNF transport (Gauthier et al., 2004), disruption
of microtubules (Trushina et al., 2003), interference with NMDA
receptor (NMDAR) and synaptic activity (Zeron et al., 2004) as
well as disruption of mitochondrial functioning and morphology
(Rockabrand et al., 2007; Costa and Scorrano, 2012).
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Excitotoxicity is a phenomenon driven by excessive synap-
tic accumulation of glutamate and associated with dysregulation
of intraneuronal Ca2+ ([Ca2+]i) homeostasis (Choi, 2005). A
major feature of excitotoxicity is the NMDAR/Ca2+-dependent
enhanced generation of nitric oxide (NO) and other reactive oxy-
gen species (ROS) [reviewed in Forder and Tymianski (2009) and
Szydlowska and Tymianski (2010)].
A subpopulation of striatal neurons (accounting for less
than 1% of the overall population) expresses high levels
of the enzyme nicotinamide adenine dinucleotide phosphate-
diaphorase (NADPH-d) that is the neuronal isoform of nitric
oxide synthase (nNOS) (Hope et al., 1991). Intriguingly, these
neurons expressing large amount of nNOS [hereafter called
nNOS(+) neurons] are not affected by NMDAR-dependent tox-
icity and spared in the striatum of HD patients (Ferrante et al.,
1985; Koh et al., 1986; Koh and Choi, 1988). The molecular
and biochemical determinants of this decreased vulnerability are
still not completely known. A possible simple explanation for
the phenomenon is that nNOS(+) neurons have fewer or less
active NMDARs. To test this hypothesis, we employed single cell
Ca2+ imaging and assessed differences in NMDAR-evoked rises
in [Ca2+]i in striatal cultures, and compared responses obtained
in nNOS(+) and the overall population of striatal neurons that
express lower levels of the enzyme and hereafter called nNOS(−)
neurons.
Mitochondrial function is critical to maintaining [Ca2+]i
homeostasis (Pizzo et al., 2012). Mutant Htt promotes mitochon-
drial dysfunction and we have previously shown that specific Htt
domains are crucial to drive its mitochondrial localization and
promote dysfunction (Rockabrand et al., 2007).
Ca2+ overload in mitochondria promotes generation of free
radicals in the organelles (Dugan et al., 1995; Reynolds and
Hastings, 1995), a step that has been shown to be instru-
mental in the initiation of the excitotoxic cascade (White and
Reynolds, 1995, 1996; Nicholls and Budd, 1998; Stout et al., 1998;
Nicholls and Budd, 2000; Nicholls and Ward, 2000; Votyakova
and Reynolds, 2001; Nicholls, 2002, 2004; Nicholls et al., 2003,
2007; Rintoul et al., 2003; Reynolds et al., 2004; Vesce et al., 2004;
Votyakova and Reynolds, 2005). Thus, we also tested whether
exposure to NMDA in striatal cultures generated different levels
of mitochondrial ROS (mt-ROS) in nNOS(+) neurons compared
to the overall population of nNOS(−) cells.
MATERIALS AND METHODS
CHEMICALS
Tissue culture media and sera were purchased from GIBCO
(Life Technologies). Fluorescent calcium (fura-2 AM, and fluo-
4FF AM) and ROS (dihydrorhodamine, DHR) indicators were
purchased from Molecular Probes (Life Technologies). All other
chemicals, unless otherwise specified, were purchased from
Sigma-Aldrich.
NEURONAL STRIATAL CULTURES
All the procedures involving animals were approved by the insti-
tutional Ethics Committee (Ce.S.I.) and performed accordingly
to institutional guidelines and in compliance with national and
international laws and policies.
Striatal cell cultures were prepared from fetal (E15 or E16)
Swiss–Webster or CD1 mice. Striatal tissues were dissected in
ice-cold dissecting medium and then placed in trypsin (0.25%)
for 10min at 37◦C. Tissues were centrifuged, supernatant dis-
carded, and pellet mechanically dissociated with a glass Pasteur
pipette. Cells were then resuspended in plating medium con-
taining either: (for mixed cultures) Eagle’s Minimal Essential
Medium (with 20mM glucose, 26.2mM NaHCO3) supple-
mented with L-glutamine (2mM), 5% fetal calf serum, and 5%
horse serum (Hyclone), or (for near-pure neuronal cultures)
Neurobasal Medium supplemented with L-Glutamine (0.5mM),
5% fetal bovine serum, 5% horse serum, 1× B27, and 0.2%
penicillin/streptomycin.
To prepare mixed cultures, cell suspensions were diluted and
plated onto an astrocytes layer on 35mm culture dishes with a
glass bottom (Mat-Tek). Cells were fed twice a week with a growth
medium (containing 10% horse serum, and 2mM L-glutamine)
and after 12 days in vitro (DIV) with a serum-free medium
supplemented with 2mM L-glutamine.
For near-pure neuronal cultures, cells suspensions were diluted
and plated onto laminin/poly-DL-lysine coated glass coverslips.
Three days after plating, non-neuronal cell growth was inhibited
by adding 10μM of cytosine arabinofuranoside. Twice a week,
25% of the medium was replaced with equal amounts of fresh
Neurobasal medium.
Striatal neurons were used between 12 to 17 DIV.
IMAGING STUDIES
Ca2+ imaging employing fura-2 was performed using a Nikon
Diaphot inverted microscope equipped with a Xenon lamp, a 40×
Nikon epifluorescence oil immersion objective (N.A.: 1.3), and
a CCD camera (Quantex). Fluo-4FF experiments were instead
performed using a Nikon Eclipse TE300 inverted microscope
equipped with a Xenon lamp, a 40× Nikon epifluorescence oil
immersion objective (N.A.: 1.3) and a 12-bit Orca CCD cam-
era (Hamamatsu). DHR experiments were performed with a
confocal microscope (Noran Odyssey) equipped with an argon-
ion laser, an inverted microscope (Nikon Diaphot), and a 60×
Nikon oil-immersion objective (N.A.: 1.4). Fura-2 ratios and
DHR confocal images (and relative bright field images) were dig-
itized and analyzed using Image-1 system (Universal Imaging) or
Metamorph imaging software (Universal Imaging), respectively.
Fluo-4FF images were acquired and analyzed with Metafluor 6.0
software (Molecular Devices).
[Ca2+]i Measurements
Striatal cultures were loaded for 30min in the dark with fura-2
AM (5μM) or fluo-4FF AM (5μM) plus 0.2% Pluronic F-
127 in HEPES-buffered saline solution (HCSS) (120mM NaCl,
5.4mM KCl, 0.8mM MgCl2, 20mM HEPES, 15mM glucose,
1.8mM CaCl2, 10mM NaOH, pH 7.4), washed, and incubated
for further 30min in HCSS. In fura-2 experiments [Ca2+]i was
determined using the ratio method described by Grynkiewicz
et al. (1985). Fura-2 (Ex λ: 340, 380 nm, Em λ: 510 nm) calibrated
values were obtained by determining Rmin and Rmax using: EGTA
(10mM) and ionomycin (10μM) in 0 Ca2+ buffer for Rmin, and
Ca2+ (10mM) with ionomycin (10μM) for Rmax. Fura-2 Kd
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was set at 225 nM. Results are reported as mean [Ca2+]i nM ±
SEM. In fluo-4FF (Ex λ: 490 nm, Em λ: 510 nm) fluorescence
changes of each cell (Fx) were normalized to basal fluorescence
intensity (F0). Results are expressed as mean Fx/F0 ± SEM val-
ues. In all experiments, NMDA (50μM + 10μM glycine) was
applied for 20 s and then removed through a rapid perfusion
system.
ROS ProductionMeasurements
Cells were loaded with DHR (5μM) in the dark in a 37◦C/5%
CO2 incubator for 30min and then studied with confocal imag-
ing. DHR was excited at 488 nm and emission collected at
>515 nm. In order to minimize DHR photo-oxidation, laser
beamwas used to less than 5% of full power and image acquisition
intervals minimized to≤ 2 s every 5min. DHRwas maintained in
the buffer throughout all the imaging session to maintain probe
equilibration between the inside and outside of cells.
NMDA exposure was performed by adding NMDA (50μM +
10μM glycine) to the baseline HCSS solution for 5min.
NMDARs activation was then halted by addition of 10μM
MK-801 and neurons imaged for additional 25min.
NADPH-DIAPHORASE STAINING
To identify what we call nNOS(+) neurons we employed the
NADPH-d staining procedure (Koh et al., 1986). To that aim,
after Ca2+ i or DHR experiments, cultures were rinsed three
times in ice-cold TBS and fixed for 30min at 4◦C in 4%
paraformaldehyde/0.1M PBS buffer. After fixation, dishes were
washed with TBS and staining solution applied for 1 h at 37◦C.
NADPH-d staining solution contained: 0.1mM Tris/HCl, 0.2%
Triton X-100, 1.2mM sodium azide, 0.2mM nitrotetrazolium
blue, and 1mM NADPH, pH 7.2. The staining solution was
removed and cultures rinsed with TBS. After staining, dishes
were re-inserted in the microscope stage and fields re-matched
with those previously imaged with fura-2, fluo-4FF, and DHR.
nNOS(+) neurons identified as NADPH-d (+) under bright-
field illumination were then evaluated for their responses in the
imaging experiments.
STATISTICAL ANALYSIS
Grubbs’ test was performed to detect outliers, the significance
level was set at α = 0.05 (no nNOS(+) were found to be sig-
nificant outliers). Statistical analysis was performed using the
Student’s t-test for unpaired data. Results were considered statis-
tically significant at p < 0.05.
RESULTS
[Ca2+]i RISES UPON NMDA EXPOSURE IN nNOS(+) AND (−) STRIATAL
NEURONS
In this set of experiment, we tested whether nNOS(+) possess
functional NMDARs and evaluated NMDAR-dependent [Ca2+]i
increases as an indirect parameter of receptor activity. [Ca2+]i
rises upon NMDA exposure were investigated with single cell
Ca2+ imaging. This indirect assay is the only possible way to
study NMDAR activity in specific nNOS(+) neurons. A more
direct approach would have been to investigate NMDAR-evoked
currents with patch clamp electrophysiology. Unfortunately, this
approach is highly unfeasible given the extremely low density
(<1%) of nNOS(+) neurons in our striatal cultures along with
the absence of any suitable marker to identify these neurons
when in culture, two factors making very unlikely the pos-
sibility of successfully patching on to these cells in adequate
numbers.
Striatal cultures loaded with fura-2, a high affinity Ca2+
probe (Kd = 225 nM), were exposed to NMDA (50μM +
10μM glycine) and [Ca2+]i elevation assessed during and after
the challenge. In this set of experiments, we observed that
NMDAR-dependent [Ca2+]i rises occurring in nNOS(+) were
not statistically different from those found in the overall pop-
ulation of nNOS(−) neurons (Figures 1A,B). To dissect and
possibly reveal more subtle differences in [Ca2+]i handling
between nNOS(+) and (−) neurons, we analyzed peak ampli-
tudes, areas under the curve (an index of the overall cytoso-
lic Ca2+ load) and recovery phase time (τ) of the [Ca2+]i
changes (Figures 1C–E). None of these parameters showed sta-
tistically significant differences between the two neuronal pop-
ulations. Analysis of baseline [Ca2+]i levels also showed no
differences between nNOS(+) and (−) neurons at rest (data
not shown).
In the fura-2 data set we noticed that some neurons showed
[Ca2+]i responses in the micromolar range. Fura-2 is a high
affinity Ca2+ probe, a technical limitation that leads to under-
estimating peak [Ca2+]i rises for values above 1μM (Hyrc et al.,
1997). We therefore repeated the same set of experiments with the
low affinity Ca2+ indicator fluo-4FF, a probe that, with a Kd of
9.7μM, is suitable for the detection of [Ca2+]i changes occurring
in the 1μMto 1mM range. Fluo-4FF experiments confirmed that
NMDAR-dependent [Ca2+]i increases are identical in nNOS(+)
and (−) neurons (Figures 2A–E). Of note, different from fura-2
experiments, in the fluo-4FF data set we observed a decreased
recovery time in all neurons, a phenomenon that likely reflects
the lower affinity of the probe for Ca2+.
Finally, we assessed whether nNOS(+) neurons show differ-
ences in [Ca2+]i response via other glutamatergic ionotropic
receptors (i.e., AMPARs). To that aim, fura-2 loaded striatal neu-
rons were exposed to kainate (50μM) and [Ca2+]i levels analyzed
in terms of agonist-evoked peak levels as well as overall cytoso-
lic cation loads (as indicated by evaluation of the area under the
curve of fura-2 signals). Even in this set of experiments, we did not
observe significant differences between nNOS(+) and (−) striatal
neurons (data not shown).
In summary, Ca2+ imaging experiments indicated that
nNOS(+) neurons possess fully functional NMDARs.
ROS GENERATION UPON NMDA EXPOSURE IN nNOS(+) AND (−)
NEURONS
Aberrant Ca2+ entry through NMDARs results in cytosolic
Ca2+ overload, dissipation of the mitochondrial inner mem-
brane potential, opening of the permeability transition pore, and
production of mt-ROS (Rizzuto et al., 2012). ROS are major con-
tributors to excitotoxicity (Choi, 1992a,b; Dugan and Choi, 1994;
Sayre et al., 2008). As mentioned above, NADPH diaphorase is
the neuronal nNOS enzyme (Hope et al., 1991). Thus, nNOS(+)
neurons are likely to be chronically exposed to an intracellular
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FIGURE 1 | NMDAR-dependent [Ca2+]i rises in striatal cultured neurons
evaluated with a high affinity Ca2+-sensitive probe. (A) Fluorescence
images of fura-2 loaded striatal neurons before (top), and upon NMDA
exposure (middle). Bright field image (bottom) showing stained nNOS(+),
indicated by arrows, and nNOS(−)neurons. (B) Time course of
NMDAR-dependent [Ca2+]i rises, traces of a single experiment [NOS(+)
(n = 2) and nNOS(−) (n = 47)], representative of 20 independent
experiments. (C) Average [Ca2+ ]i peak amplitude in the two neuronal
populations (p = 0.42). (D) [Ca2+ ]i dynamics expressed as area under the
curve (p = 0.70). (E) Recovery phase following NMDA exposure (p = 0.43).
Results are expressed as mean values ± SEM; nNOS(+) n = 22; nNOS(−)
n = 560.
environment that is constantly confronted (and needs to be
equipped to deal) with the presence of high NO levels.
To investigate mt-ROS levels generated by NMDAR activa-
tion, striatal neurons were first loaded with the ROS sensitive
probe DHR (Henderson and Chappell, 1993) and fluorescent
changes evaluated before, during, and after NMDA exposure with
confocal microscopy. Native DHR is uncharged, not fluorescent,
and passively diffuses through membranes. Once in the presence
of ROS, DHR is oxidized to the cationic fluorescent product,
rhodamine 123, allowing the investigation of mitochondrial ROS
production (Dugan et al., 1995).
In this set of experiments DHR-loaded neurons, after acqui-
sition of baseline fluorescence levels, were exposed to NMDA
(50 + 10 μM glycine) for 5min, NMDAR activation was then
halted by addition of the receptor antagonist (MK-801; 10μM)
and fluorescence changes evaluated up to 30min. Confocal DHR
imaging revealed that NMDA application failed to promote sig-
nificant fluorescence changes in nNOS(+) neurons while (−)
neurons showed significant signal rises (Figure 3).
Thus, DHR experiments revealed that NMDA exposure fails to
elicit production of mt-ROS in nNOS(+) striatal neurons.
DISCUSSION
nNOS(+) neurons are spared from NMDAR-driven excitotoxi-
city, a phenomenon that has puzzled the field for many years
(Beal et al., 1986; Koh and Choi, 1988; Kumar, 2004; El Ghazi
et al., 2012). Our study offers two major findings that may help to
unravel the mechanisms underlying the decreased vulnerability
of these neurons and offer additional insight for their increased
survival in the context of HD.
Firstly, nNOS(+) striatal neurons possess fully functional
NMDARs and respond to receptor activation with [Ca2+]i rises
that do not differ for amplitude and temporal dynamics to the
ones observed in the overall population of nNOS(−) neurons.
Secondly, in nNOS(+) neurons, NMDAR activation does not lead
to generation ofmt-ROS, thereby occluding a critical downstream
event of their excitotoxic cascade.
NMDAR-dependent deregulation of intraneuronal [Ca2+]i
levels upon prolonged or excessive glutamate exposure is the event
that starts excitotoxicity (Choi, 1992a,b, 2005). Thus, the reduced
vulnerability of nNOS(+) neurons to excitotoxic challenges could
have been easily explained by reduced expression or functioning
of NMDARs in this subpopulation.
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FIGURE 2 | NMDAR-dependent [Ca2+]i rises in striatal cultured neurons
evaluated with a low affinity Ca2+-sensitive probe. (A) Fluorescence
images of fluo4-FF loaded striatal neurons before (top) and upon NMDA
exposure (middle). Bright field image (bottom) showing stained nNOS(+),
indicated by arrows, and nNOS(−) neurons. (B) Time course of
NMDAR-dependent [Ca2+ ]i rises, traces of a single experiment [nNOS(+)
(n = 1) and nNOS(−) (n = 18)], representative of 12 independent
experiments. (C) Average Ca2+i peak amplitude in the two neuronal
populations (p = 0.36). (D) [Ca2+]i dynamics expressed as area under the
curve (p = 0.24). (E) Recovery phase following NMDA exposure (p = 0.43).
Results are expressed as mean values ± SEM; nNOS(+) n = 13; nNOS(−)
n = 165.
Our data lend us to hypothesize an alternative view and finally
demonstrate that these neurons are most likely resistant not
because they differ in number or functionality of NMDARs but,
on the contrary, because they are able to set in motion protective
events acting downstream to block a key step in the injurious cas-
cade set in motion by NMDAR activation: the intraneuronal raise
of mt-ROS levels.
ROS play important roles in several biological functions and
are critical mediators of physiological or death signaling (Huang
and McNamara, 2012; Ray et al., 2012). Upon excitotoxic condi-
tions, NMDAR-driven production of high levels of cytosolic and
mitochondrial ROS as well as nitrosative species leads to neu-
ronal death (Floyd, 1999; Droge, 2002; Lau and Tymianski, 2010).
Neurons maintain a redox homeostasis and counteract these
oxidative and nitrosative hits by employing several endogenous
scavenging mechanisms (Greenlund et al., 1995) like superoxide
dismutases, catalases, and glutathione peroxidases.
As nNOS(+) neurons express high levels of nNOS (Hope
et al., 1991) and are thereby producing large amounts of NO,
it is conceivable that they are primed to deal with an oxidizing
intracellular environment and possess an enhanced capability to
neutralize this challenge.
Landmark findings support this idea and, in fact, indicate that
nNOS(+) express high levels of manganese superoxide dismutase
(MnSOD) (Gonzalez-Zulueta et al., 1998). MnSOD, a mito-
chondrial enzyme, neutralizes free radicals. The enzyme confers
resistance against NMDA- and NO-mediated toxicity both in vivo
and in vitro by preventing the generation of toxic peroxyni-
trite originating from the NO and O−2 interaction (Beckman
and Koppenol, 1996; Gonzalez-Zulueta et al., 1998; Brown,
2010). Thus, our data suggest a conceptual framework in which
enhancedMnSOD activity in nNOS(+) neuronsmight lead to the
reduced ROS generation that we find upon NMDA exposure and
provides potential explanation for their decreased vulnerability to
NMDAR-mediated neuronal death.
Our results are providing support for the idea that mitochon-
dria play a strategic role in the phenomenon. We acknowledge
that future experiments are needed to clarify whether increased
MnSOD activity is indeed play amajor role in the neuroprotective
pathway. We show that NMDA exposure produces [Ca2+]i levels
that are similar in nNOS(+) and (−) striatal neurons. We also
show that these excitotoxic Ca2+ rises fail to promote significant
ROS raises in the mitochondria of nNOS(+) neurons. Thus, in
nNOS(+) neurons, the behavior of mitochondria, critical actors
of the excitotoxic cascade, differ.
Two major arguments support this assumption. In the Ca2+
imaging experiments we have shown that nNOS(+) neurons
face the same NMDAR-driven Ca2+ overload. If one has to fit
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FIGURE 3 | NMDAR-dependentmitochondrial ROS production in striatal
cultured neurons. (A) Confocal images of basal levels of fluorescence of
DHR-loaded neurons prior to NMDA stimulation. (B) DHR fluorescence
25min after a 5min NMDA exposure. (C) Bright field image showing stained
nNOS(+), indicated by arrow, and nNOS(−) neurons. (D) Quantification of
DHR fluorescence increases 25min after NMDA exposure (∗p < 0.001).
Results are expressed as mean % of Fx /F0 ± SEM; nNOS(+) n = 19;
nNOS(−) n = 142 from 18 independent experiments.
these data and the DHR results in a comprehensive conceptual
framework, it can be hypothesized that either: (1) mitochon-
dria of nNOS(+) neurons are allowing less Ca2+ uptake (thereby
decreasing the overall generation of Ca2+-dependent mt-ROS)
or (2) nNOS(+) neurons have developed ways to counteract the
generation of mt-ROS.
When considering the first hypothesis, it should be underlined
that our Ca2+ imaging experiments take in account and report
changes of cation levels occurring in the cytosol, a phenomenon
that is the net result of simultaneous and concerted activities
of many Ca2+ homeostatic systems (Pizzo et al., 2012; Rizzuto
et al., 2012). The fact that we observed similar NMDAR-driven
Ca2+ loads in the two neuronal subpopulations could, in the-
ory, be explained by compensatory mechanisms occurring in
nNOS(+) neurons that prevent Ca2+ overloads in mitochondria.
For this mechanism to work, one has to infer that these cells
may have enhanced expression and/or functioning of the plasma-
membrane Ca2+-ATPases (PMCA), a key pathway for Ca2+
extrusion, a possibility that we have not tested yet. Differences in
activity of the other major cellular system for Ca2+ extrusion, the
plasmatic Na+-Ca2+ exchanger (NCX), are unlikely as excitotoxic
conditions (like the one used in our setting) favor either a NCX
reverse operational mode (thereby leading the exchanger to serve
as pathway for Ca2+ entry) (Orrenius et al., 2003) or NCX func-
tional blockade by calpain-mediated cleavage of the exchanger
(Bano et al., 2005).
Enhanced functioning of intracellular Ca2+ stores (i.e., the
endoplasmic reticulum; ER) is also unlikely to work to decrease
Ca2+ rises in nNOS(+) neurons. Accordingly to the “hot spot”
hypothesis proposed by Rizzuto et al. (1998), Ca2+ overload
in the ER is a detrimental source for ROS generation as the
cation eventually exits the ER and is taken up by mitochon-
dria located in the ER vicinity, thereby providing the driving
force for production of mt-ROS. Thus, if nNOS(+) neurons do
overdrive the ER to maintain Ca2+ homeostasis such compen-
satory mechanism should be counterbalanced by enhanced levels
of mt-ROS, the opposite of what we observed in our nNOS(+)
neurons.
The idea that mitochondria of nNOS(+) sequester equal
amounts of Ca2+ but respond to this hit with a decreased genera-
tion of ROS is strongly suggested by previous findings (Gonzalez-
Zulueta et al., 1998) that indicate a major role for MnSOD in
promoting protection against NMDAR-mediated oxidative stress
in nNOS(+) neurons. Within this framework, we do speculate
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that the observed reduction of ROS levels in nNOS(+) neurons
may be due to higher scavenging capabilities of this neuronal
subpopulation.
In summary, our data offer complementary data that substan-
tiate a major role for mitochondria in promoting the reduced
vulnerability to NMDA in nNOS(+) striatal neurons. Given the
role played by polyQ Htt in affecting mitochondrial functioning,
this mechanism can be particularly relevant in the context of
the neuronal loss occurring in the striatum of HD patients and
provide targets for therapeutic intervention.
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